Placental transfer of the HIV integrase inhibitor dolutegravir in anex vivohuman cotyledon perfusion model

Pharmacokinetics of Dolutegravir in a Premature Neonate after HIV Treatment Intensification during Pregnancy

(2015) J. B. Pain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Regulation of drug transporter expression and function in the placenta

(2015) Frantisek Staud et al.   Expert Opinion on Drug Metabolism & Toxicology

Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection

(2015) Pauline Bollen et al.   Expert Opinion On Drug Safety

Protecting the Fetus Against HIV Infection: A Systematic Review of Placental Transfer of Antiretrovirals

(2014) Shelley A. McCormack et al.   CLINICAL PHARMACOKINETICS

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

(2013) Mackenzie L. Cottrell et al.   CLINICAL PHARMACOKINETICS

Pharmacological considerations on the use of antiretrovirals in pregnancy

(2013) Angela Colbers et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

(2013) Francois Raffi et al.   LANCET

The Human Placental Perfusion Model: A Systematic Review and Development of a Model to Predict In Vivo Transfer of Therapeutic Drugs

(2011) J R Hutson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Quality assessment of a placental perfusion protocol

(2010) Line Mathiesen et al.   REPRODUCTIVE TOXICOLOGY

In Vivo Glucuronidation Activity of Drugs in Neonates: Extensive Interindividual Variability Despite Their Young Age

(2009) Karel Allegaert et al.   THERAPEUTIC DRUG MONITORING